Literature DB >> 33753207

Characterization of Brucella abortus S19 as a challenge strain for use in a mouse model of brucellosis.

Jessica M Jacob1, Roy Curtiss2.   

Abstract

The objective of this project was to conduct a feasibility study to determine whether the Brucella abortus S19 vaccine infects and persists in mice and determine whether S19 can be used as a challenge strain for vaccine trial studies. Groups of BALB/c mice were inoculated (intraperitoneally, subcutaneously, intranasally) and euthanized to determine colonization titers in the spleens and lungs. This study showed that S19 does infect and persist in the tissues of mice for 8 weeks and demonstrates that S19 can be used, safely and economically under BSL2 containment, as the challenge strain for future trials to evaluate vaccine efficacy.
Copyright © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bacterial loads; Biosafety; Brucella abortus; Mice; Spleen; Vaccine

Year:  2021        PMID: 33753207     DOI: 10.1016/j.micinf.2021.104809

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

1.  Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review.

Authors:  Atieh Darbandi; Shabnam Zeighamy Alamdary; Maryam Koupaei; Roya Ghanavati; Mohsen Heidary; Malihe Talebi
Journal:  Front Vet Sci       Date:  2022-09-02

2.  Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response.

Authors:  Mahdieh Sarmadi; Azam Gheibi; Hossein Khanahmad; Mohammad Reza Khorramizadeh; Seyed Hossein Hejazi; Noushin Zahedi; Hamidreza Mianesaz; Khosrow Kashfi
Journal:  Vaccines (Basel)       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.